tiprankstipranks
Neurogene (NGNE)
NASDAQ:NGNE
US Market
NGNE
Neurogene
RESEARCH TOOLSreports

Neurogene (NGNE) Income Statement

607 Followers

Neurogene Income Statement

Last quarter (Q4 2025), Neurogene's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Neurogene's net income was $-24.73M. See Neurogene’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 925.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.19M$ -2.32M$ -3.26M$ -3.20M$ -42.26M
Operating Expenses
$ 100.02M$ 80.28M$ 52.32M$ 53.32M$ 8.27M
Depreciation and Amortization
$ 0.00$ 3.25M$ 3.30M$ 3.20M$ 947.00K
EBITDA
$ -103.33M$ -71.89M$ -52.29M$ -51.99M$ -49.59M
Operating Income
$ -103.21M$ -82.61M$ -55.58M$ -56.52M$ -50.53M
Other Income/Expenses
$ 12.86M$ 7.46M$ 19.27M$ 1.33M$ 17.00K
Pretax Income
$ -90.35M$ -75.14M$ -36.32M$ -55.19M$ -50.52M
Net Income
$ -90.35M$ -75.14M$ -36.32M$ -55.19M$ -50.52M
Per Share Metrics
Basic EPS
$ -4.24$ -4.28$ -2.83$ -4.30$ -0.92
Diluted EPS
$ -4.24$ -4.28$ -2.83$ -4.30$ -0.92
Weighted Average Shares Outstanding
 21.17M 17.57M 12.82M 12.82M 55.04M
Weighted Average Shares Outstanding (Diluted)
 21.17M 17.57M 12.82M 12.82M 55.04M
Currency in USD

Neurogene Earnings and Revenue History